No, you do not have to be clinically obese to be a candidate for GLP-1 medications like semaglutide or tirzepatide
Some start with semaglutide given its lower price and excellent results, then switch to tirzepatide if they plateau or want to maximize outcomes
consider reducing doses of these medications when initiating tirzepatide Signs of acute kidney injury, particularly in patients experiencing severe gastrointestinal adverse effects with dehydration Symptoms of pancreatitis (severe abdominal pain radiating to the back, nausea, vomiting) Gallbladder disease (right upper quadrant pain, fever, jaundice) Gastrointestinal adverse effects, which occur commonly but are usually self-limited Tirzepatide is not recommended for patients with severe gastrointestinal disease, including severe gastroparesis
Alcohol may worsen common GLP-1 side effects including nausea, vomiting, and gastrointestinal discomfort
Proteccin gastrointestinal: El BPC-157 protege la mucosa gstrica e intestinal contra diversos agentes agresivos (AINE, alcohol, estrs)